Ciancio G et al. |
Current advantage of FK 506 in cadaveric kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8623207
|
Pham SM et al. |
Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience. |
1996 |
Transplant. Proc. |
pmid:8623208
|
Satomura K et al. |
Pharmacokinetics of FK 506 in living-related liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623209
|
Loss M et al. |
Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy. |
1996 |
Transplant. Proc. |
pmid:8623210
|
Fryer JP et al. |
Bacterial translocation in a large-animal model of small-bowel transplantation. Portal vs systemic venous drainage and the effect of tacrolimus immunosuppression. |
1996 |
Arch Surg |
pmid:8546583
|
Bechstein WO et al. |
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623211
|
Sher LS et al. |
Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623212
|
Millis JM et al. |
Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. |
1996 |
Transplant. Proc. |
pmid:8623213
|
Washburn WK et al. |
Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8623214
|
Regazzi MB et al. |
Interaction between FK 506 and diltiazem in an animal model. |
1996 |
Transplant. Proc. |
pmid:8623215
|
Kyo M et al. |
Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin. |
1996 |
Transplant. Proc. |
pmid:8623457
|
D'Silva M et al. |
Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506. |
1996 |
Transplant. Proc. |
pmid:8623467
|
Pirenne J et al. |
Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients. |
1996 |
Transplant. Proc. |
pmid:8623472
|
Ciancio G et al. |
Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy. |
1996 |
Transplant. Proc. |
pmid:8623473
|
D'Silva M et al. |
Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. |
1996 |
Transplant. Proc. |
pmid:8623476
|
Klintmalm GB |
Clinical use of FK 506 in liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623484
|
Butt TR et al. |
Molecular basis of immunosuppressive drug action: regulation of steroid receptor-mediated transcription by FK 506. |
1996 |
Transplant. Proc. |
pmid:8623486
|
Kawashima M et al. |
Tacrolimus concentrations in blood during topical treatment of atopic dermatitis. |
1996 |
Lancet |
pmid:8898050
|
Drake M et al. |
The immunosuppressant FK506 ameliorates ischaemic damage in the rat brain. |
1996 |
Acta Physiol. Scand. |
pmid:8899062
|
Beauparlant P and Hiscott J |
Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis. |
1996 |
Cytokine Growth Factor Rev. |
pmid:8899295
|
Kaplan B et al. |
Frequency of hyperkalemia in recipients of simultaneous pancreas and kidney transplants with bladder drainage. |
1996 |
Transplantation |
pmid:8900321
|
Franke EK and Luban J |
Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. |
1996 |
Virology |
pmid:8806510
|
Ichikawa Y et al. |
Three-times-daily monotherapy with tacrolimus (FK 506) in kidney transplantation. |
1996 |
Int. J. Urol. |
pmid:8776613
|
Mugiya S et al. |
Renal blood flow and serotonin metabolism in tacrolimus treated rats. |
1996 |
Int. J. Urol. |
pmid:8776615
|
Dmitrewski J et al. |
Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression. |
1996 |
J. Hepatol. |
pmid:8778189
|
Schwarz A |
[Drug-induced kidney damage]. |
1996 |
Z Arztl Fortbild (Jena) |
pmid:8779233
|
Newell KA et al. |
Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. |
1996 |
Transplantation |
pmid:8779685
|
Lufft V et al. |
Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. |
1996 |
Transplantation |
pmid:8779695
|
Cicalese L et al. |
Effect of FK506 on the mucosal perfusion of the rat intestinal allograft. |
1996 |
Transplant. Proc. |
pmid:8907959
|
Reggiani P et al. |
Oral administration of FK 506 in a swine model of liver-small bowel allotransplantation. |
1996 |
Transplant. Proc. |
pmid:8907965
|
Spada M et al. |
Bacterial translocation is enhanced in pig intestinal transplantation when the colon is included in the graft. |
1996 |
Transplant. Proc. |
pmid:8907997
|
Alessiani M et al. |
Intestinal transplantation with and without the colon in FK 506 immunosuppressed pigs. |
1996 |
Transplant. Proc. |
pmid:8908021
|
Asfar S et al. |
Small bowel transplantation. |
1996 |
Transplant. Proc. |
pmid:8908039
|
Reyes J et al. |
Intestinal transplantation in children: five-year experience. |
1996 |
Transplant. Proc. |
pmid:8908042
|
Rao AS et al. |
Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. |
1996 |
Transplant. Proc. |
pmid:8908140
|
Opelz G |
Comparison of FK506 and cyclosporine. |
1996 |
Transplantation |
pmid:8830844
|
Alper G and Small SL |
Cerebrospinal fluid after organ transplantation. |
1996 |
Transplant. Proc. |
pmid:8908142
|
Ho S et al. |
The mechanism of action of cyclosporin A and FK506. |
1996 |
Clin. Immunol. Immunopathol. |
pmid:8811062
|
Nishino H et al. |
3-Nitropropionic acid produces striatum selective lesions accompanied by iNOS expression. |
1996 |
J. Chem. Neuroanat. |
pmid:8811425
|
Sonatore LM et al. |
The utility of FK506-binding protein as a fusion partner in scintillation proximity assays: application to SH2 domains. |
1996 |
Anal. Biochem. |
pmid:8811923
|
Jonas S et al. |
Conversion to tacrolimus after liver transplantation. |
1996 |
Transpl. Int. |
pmid:8748407
|
Cooley HM et al. |
Resolution of pyoderma gangrenosum using tacolimus (FK-506) |
1996 |
Aust N Z J Med |
pmid:8744629
|
Guérette B et al. |
Increased interferon-gamma mRNA expression following alloincompatible myoblast transplantation is inhibited by FK506. |
1996 |
Muscle Nerve |
pmid:8965835
|
Sharkey J et al. |
Tacrolimus (FK506) ameliorates skilled motor deficits produced by middle cerebral artery occlusion in rats. |
1996 |
Stroke |
pmid:8969794
|
Hedayat S et al. |
Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants. |
1996 |
J Biopharm Stat |
pmid:8969977
|
Taler SJ et al. |
Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. |
1996 |
Transplantation |
pmid:8970613
|
Tanabe K et al. |
Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8658670
|
Shuker SB et al. |
Discovering high-affinity ligands for proteins: SAR by NMR. |
1996 |
Science |
pmid:8929414
|
Sugito K et al. |
A comparative study of clinicopathologic characteristics of renal allografts under cyclosporine and FK506 immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8658683
|
Degawa H et al. |
Blocking of ICAM-1 and LFA-1 in rat liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8658695
|
Watanabe K et al. |
Immunosuppressive effect of bactobolamine in rat liver allotransplantation. |
1996 |
Transplant. Proc. |
pmid:8658697
|
Tojimbara T et al. |
Cyclosporine and tacrolimus both suppress activation of Kupffer cells in vitro. |
1996 |
Transplant. Proc. |
pmid:8658704
|
Yuzawa K et al. |
Topical immunosuppression in skin grafting with FK 506 ointment. |
1996 |
Transplant. Proc. |
pmid:8658707
|
Yagura K et al. |
Pharmacokinetic characteristics of two types of liposomal FK 506. |
1996 |
Transplant. Proc. |
pmid:8658708
|
Ogawa N et al. |
Suppressive effects of combination therapy with mizoribine and FK 506 on the development of accelerated coronary artery disease and myocardial rejection after heart transplantation. |
1996 |
Transplant. Proc. |
pmid:8658710
|
Rokaw MD et al. |
Rapamycin inhibits protein kinase C activity and stimulates Na+ transport in A6 cells. |
1996 |
J. Biol. Chem. |
pmid:8943313
|
Matsui A et al. |
Apparently increased trough levels of tacrolimus caused by acute infantile diarrhea in two infants with biliary atresia after liver transplantation. |
1996 |
Acta Paediatr Jpn |
pmid:9002314
|
Adachi M et al. |
Interleukin-2 (IL-2) upregulates BAG-1 gene expression through serine-rich region within IL-2 receptor beta c chain. |
1996 |
Blood |
pmid:8943845
|
DeCenzo MT et al. |
FK506-binding protein mutational analysis: defining the active-site residue contributions to catalysis and the stability of ligand complexes. |
1996 |
Protein Eng. |
pmid:9005438
|
Przepiorka D et al. |
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation. |
1996 |
Blood |
pmid:8943876
|
Blecher O et al. |
A novel plant peptidyl-prolyl-cis-trans-isomerase (PPIase): cDNA cloning, structural analysis, enzymatic activity and expression. |
1996 |
Plant Mol. Biol. |
pmid:8980498
|
McCall E et al. |
Effects of FK-506 on contraction and Ca2+ transients in rat cardiac myocytes. |
1996 |
Circ. Res. |
pmid:8943949
|
Winkler M et al. |
Evaluation of the Pro-Trac tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of tacrolimus levels in patients after kidney, heart, and liver transplantation. |
1996 |
Ther Drug Monit |
pmid:8946659
|
Nichterlein T et al. |
Effects of FK-506 on the course of murine salmonellosis. |
1996 |
J Chemother |
pmid:8981186
|
MacFarlane G et al. |
A simplified whole blood enzyme-linked immunosorbent assay (ProTrac II) for tacrolimus (FK506) using proteolytic extraction in place of organic solvents. |
1996 |
Ther Drug Monit |
pmid:8946668
|
Redmon JB et al. |
Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. |
1996 |
J. Clin. Invest. |
pmid:8981925
|
Brunet M et al. |
Comparative analysis of tacrolimus (FK506) in whole blood liver transplant recipients by PRO-TRAC enzyme-linked immunosorbent assay and microparticle enzyme immunoassay IMX methods. |
1996 |
Ther Drug Monit |
pmid:8946669
|
Sempuku T et al. |
Osteogenic potential of allogeneic rat marrow cells in porous hydroxyapatite ceramics: a histological study. |
1996 |
J. Orthop. Res. |
pmid:8982133
|
Alak AM and Lizak P |
Stability of FK506 in blood samples. |
1996 |
Ther Drug Monit |
pmid:8721287
|
Yu C et al. |
Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation. |
1996 |
Bone Marrow Transplant. |
pmid:8722370
|
Fealy MJ and Press BH |
Pinpointing the moment of allograft rejection. |
1996 |
J Hand Surg Am |
pmid:8724501
|
Hall MN |
The TOR signalling pathway and growth control in yeast. |
1996 |
Biochem. Soc. Trans. |
pmid:8674674
|
Mattila PS |
The actions of cyclosporin A and FK506 on T-lymphocyte activation. |
1996 |
Biochem. Soc. Trans. |
pmid:8674715
|
Adams DH and Liu Q |
FK506 inhibits human lymphocyte migration and the production of lymphocyte chemotactic factors in liver allograft recipients. |
1996 |
Hepatology |
pmid:8675167
|
Jordan ML et al. |
The use of tacrolimus in renal transplantation. |
1996 |
World J Urol |
pmid:8873438
|
Wada Y et al. |
BCX-34: a novel T-cell selective immunosuppressant: purine nucleoside phosphorylase (PNP) inhibitor. |
1996 |
Artif Organs |
pmid:8853794
|
Clark W |
Tacrolimus: immunosuppression following liver and kidney transplant. |
1996 |
J Clin Pharm Ther |
pmid:8873845
|
Lochmüller H et al. |
Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. |
1996 |
Gene Ther. |
pmid:8854096
|
DiMartini AF et al. |
Prospective study of FK506 side effects: anxiety or akathisia? |
1996 |
Biol. Psychiatry |
pmid:8874843
|
Horn F and Gross J |
A role for calcineurin in Dictyostelium discoideum development. |
1996 |
Differentiation |
pmid:8855370
|
Lu YF et al. |
Calcineurin inhibitors, FK506 and cyclosporin A, suppress the NMDA receptor-mediated potentials and LTP, but not depotentiation in the rat hippocampus. |
1996 |
Brain Res. |
pmid:8874888
|
Barkholt LM et al. |
Epstein-Barr virus DNA in serum after liver transplantation--surveillance of viral activity during treatment with different immunosuppressive agents. |
1996 |
Transpl. Int. |
pmid:8875785
|
Shapiro R et al. |
Tacrolimus in pediatric renal transplantation. |
1996 |
Transplantation |
pmid:8990356
|
Morris-Stiff G et al. |
Haemolytic uraemic syndrome associated with OKT3. |
1996 |
Transpl. Int. |
pmid:8875800
|
Przepiorka D et al. |
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus. |
1996 |
Transplantation |
pmid:8990368
|
Kitagawa H et al. |
Cloning and high expression of rabbit FKBP25 in cornea. |
1996 |
Jpn. J. Ophthalmol. |
pmid:8876379
|
Kay JE |
Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases. |
1996 |
Biochem. J. |
pmid:8670043
|
Benelli U et al. |
FK-506 delays corneal graft rejection in a model of corneal xenotransplantation. |
1996 |
J Ocul Pharmacol Ther |
pmid:8951679
|
Schmaldienst S and Horl WH |
Bacterial infections during immunosuppression - immunosuppressive agents interfere not only with immune response, but also with polymorphonuclear cell function. |
1996 |
Nephrol. Dial. Transplant. |
pmid:8672015
|
Hartley AD et al. |
cAMP inhibits bud growth in a yeast strain compromised for Ca2+ influx into the Golgi. |
1996 |
Mol. Gen. Genet. |
pmid:8709962
|
Tokime T et al. |
Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil. |
1996 |
Neurosci. Lett. |
pmid:8710192
|
Dan Y et al. |
IL-3 augments TCR-mediated responses of type 2 CD4 T cells. |
1996 |
J. Immunol. |
pmid:8598473
|
Soubrane O and Houssin D |
[Liver transplantation. Current aspects]. |
1996 |
Presse Med |
pmid:8728904
|
Lampen A et al. |
Metabolism of the macrolide immunosuppressant, tacrolimus, by the pig gut mucosa in the Ussing chamber. |
1996 |
Br. J. Pharmacol. |
pmid:8732283
|
Beretta L et al. |
Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. |
1996 |
EMBO J. |
pmid:8599949
|
Saada V et al. |
Comparative evaluation of in vitro and in vivo immunosuppressive potential of cyclosporin G with cyclosporin A and FK-506. |
1996 |
Int. J. Immunopharmacol. |
pmid:8732436
|
Inomata Y et al. |
The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. |
1996 |
Transplantation |
pmid:8600632
|
Asante-Korang A et al. |
Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects. |
1996 |
J. Heart Lung Transplant. |
pmid:8732602
|
Gruessner RW et al. |
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. |
1996 |
Transplantation |
pmid:8600635
|
Rifai N et al. |
The role of lipoproteins in the transport and uptake of cyclosporine and dihydro-tacrolimus into HepG2 and JURKAT cell lines. |
1996 |
Clin. Biochem. |
pmid:8601324
|